Feds want Pharma to disclose drug prices in TV ads:
Drug companies will be required to disclose prices in television ads under a Trump administration final rule announced Wednesday.
Under the new policy, which was announced by Health and Human Services Secretary Alex Azar, drug manufacturers will need to state the list price of a 30-day supply of any drug that is covered through Medicare and Medicaid and costs at least $35 a month.
The new rule is one of the boldest steps the administration has taken in its efforts to bring transparency to the opaque system of drug prices, and puts Trump officials squarely at odds with the drug industry lobby, as well as television and ad industry groups.
“American patients deserve to know the prices of the healthcare they receive,” Azar said in a statement. “Patients who are struggling with high drug costs are in that position because of the high list prices that drug companies set.”
President Trump has made lowering drug prices a priority of his administration, and has called for industry behavior to drastically change.
According to HHS, the 10 most commonly advertised drugs have list prices ranging from $488 to $16,938 per month for a usual course of therapy. Under the rule, companies will be required to post that information in clear, legible text onscreen at the end of the ad.
Under the rule, the agency will publish a list of companies that don’t comply with the policy. Those companies would also be subject to potential litigation.
News 
Market Data 
Discover 
